I think it’s because of past history with mRNA vaccines,

New Post Public Reply Private Reply Replies (1) Message Board
rjs9787 balleroni #26585
355
I think it’s because of past history with mRNA vaccines, low sample size of current Covid related tests, effectiveness that wakes over time which will lead to the need for multiple boosters, plus encoding + including the full spike protein could lead to serious adverse events that won’t be known for a longer amount of time.

“Limitations of our clinical study include the small sample size and its restriction to participants below 55 years of age. Another constraint is that we did not perform further T cell analysis (for example, deconvolution of epitope diversity, characterization of HLA restriction, T cell phenotyping and TCR repertoire analysis) before and after vaccination, because of the limited blood volumes that were available for biomarker analyses. Similarly, we did not assess the induction of tissue-resident memory CD8+ T cells. Further, as vaccine-induced immunity can wane over time, it is important to study the persistence of potentially protective immune responses. Samples to assess persistence are not yet available but are planned in the study protocol and will be reported elsewhere.”

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Opus Water Emerges as a Leader in Engineered Water Solutions

Updated Category News Views 447

Opus Water Sets New Standards in Water Solutions Opus Water is an innovative company poised to change the landscape of water management solutions. Focused on delivering reliable and effective products, Opus Water is addressing challenges in water, wastewater, and industrial process fluids. With the backing of XPV Water Partners, this newly established entity strives to...

Continue Reading
BAOS Stock Hits New Heights with Investor Enthusiasm

Updated Category News Views 164

BAOS Stock Surges to 52-Week High In a remarkable display of market confidence, Baosheng Media Group Holdings Limited (BAOS) has achieved a significant milestone by reaching a 52-week high of $7.33 per share. This surge demonstrates the strong backing from investors and the company's solid financial standing. Company Valuation and Financial Health The micro-cap company,...

Continue Reading
Spectrum Pharmaceuticals, Inc. Investors Pursue Class Action Case

Updated Category News Views 227

Class Action Opportunity for Investors of Spectrum Pharmaceuticals Investors of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) are currently facing an important class action option that may represent a significant opportunity for compensation. With an ongoing lawsuit that claims the company made misleading statements about its clinical trial, specifically related to the...

Continue Reading
Capital Power's Vision for a Cleaner Energy Future at Climate Week

Updated Category News Views 261

Capital Power's Commitment to Sustainable Energy Solutions NEW YORK, Sept. 23, 2024 – Capital Power, a leading power producer in North America, is thrilled to take part in New York Climate Week, highlighting a crucial turning point in the evolution of energy production. The global demand for reliable, affordable energy continues to grow significantly, driven by economic...

Continue Reading
Zitro Shines Bright at the Grand G2E Las Vegas Showcase

Updated Category News Views 141

Zitro Shines Bright at the Grand G2E Las Vegas Showcase At the recent G2E Las Vegas showcase, Zitro made a significant impact by unveiling its latest innovation: FANTASY, a top-tier cabinet designed to enhance the gaming experience. This state-of-the-art cabinet goes beyond just aesthetics, integrating cutting-edge technology and emotional design elements that promise to...

Continue Reading